Related Experiment Video
Updated: Jun 26, 2026
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Association of respiratory function with sarcopenia in older outpatients: cross-sectional analysis of baseline data
Kenya Kanematsu1, Kei Matsuno2,3, Aya Shimamoto1
1Department of Clinical Laboratory, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.
Purpose:
Sarcopenia, characterized by loss of muscle mass and function, can affect the respiratory muscles and impair pulmonary function. However, evidence on the association between sarcopenia and respiratory function in older adults remains limited. This study examined the relationships among outpatients attending a hospital for older adult medicine.
Methods:
Baseline data from 810 outpatients aged ≥ 65 in the JUSTICE-TOKYO study were analyzed. Individuals with asthma, chronic obstructive pulmonary disease, or interstitial lung disease were excluded. The mean age was 78.2 ± 6.1 years, and 341 (42.1%) were male Sarcopenia was diagnosed based on 2019 Asian Working Group for Sarcopenia criteria. Pulmonary function measures included vital capacity (% predicted), forced expiratory volume in one second (% predicted), FEV1/FVC ratio, and peak expiratory flow rate (PEFR). Receiver operating characteristic (ROC) curve analyses were performed to assess the diagnostic performance of VC (% predicted) and PEFR for sarcopenia.
Results:
Sarcopenia was identified in 170 patients (21%; 102 men,68 women). Patients had a higher prevalence of myocardial infarction, heart failure, and malignancies. ROC curve analyses showed that VC (% predicted) had an optimal cutoff of 94.2% (sensitivity:0.653, specificity:0.613), and area under the curve(AUC) of 0.66. The diagnostic performance of VC (% predicted) was comparable to PEFR (AUC: 0.70 in men and 0.69 in women).
Conclusion:
Respiratory function, particularly VC (% predicted), was significantly associated with sarcopenia in older adult outpatients. VC (% predicted) demonstrates diagnostic performance comparable to PEFR and may serve as a practical parameter for sarcopenia risk identification in clinical practice.
Related Concept Videos
01:24Respiratory Capacities
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
01:19The Effect of Aging on Tissues
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...